I Daniel Limón Selected Research

Galactosides

10/2022

Neuroinflammation and galectins: a key relationship in neurodegenerative diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Daniel Limón Research Topics

Disease

2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 08/2013
2	Neuroinflammatory Diseases 10/2022 - 04/2019
2	Parkinson Disease (Parkinson's Disease) 04/2019 - 08/2013
2	Alzheimer Disease (Alzheimer's Disease) 02/2018 - 02/2009
1	Dyskinesias (Dyskinesia) 04/2019
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2015
1	Memory Disorders (Memory Loss) 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Ischemia 01/2015
1	Brain Injuries (Brain Injury) 08/2013
1	Cognitive Dysfunction 02/2009

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 04/2019 - 02/2009
2	Galectins (Galectin)IBA 10/2022 - 04/2019
2	Amyloid (Amyloid Fibrils)IBA 04/2019 - 02/2018
1	LectinsIBA 10/2022
1	Polysaccharides (Glycans)IBA 10/2022
1	GalactosidesIBA 10/2022
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 04/2019
1	Levodopa (L Dopa)FDA LinkGeneric 04/2019
1	Messenger RNA (mRNA)IBA 04/2019
1	Galectin 3 (LGALS3)IBA 04/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2015
1	Neuroprotective AgentsIBA 01/2015
1	ChemokinesIBA 01/2015
1	ZincIBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2013
1	AntioxidantsIBA 08/2013
1	Amyloid beta-PeptidesIBA 02/2009
1	amyloid beta-protein (1-42)IBA 02/2009

Therapy/Procedure

1	Therapeutics 04/2019